Details for New Drug Application (NDA): 019922
✉ Email this page to a colleague
NDA 019922 describes CORLOPAM, which is a drug marketed by Hospira and is included in one NDA. Additional details are available on the CORLOPAM profile page.
The generic ingredient in CORLOPAM is fenoldopam mesylate. There are five drug master file entries for this compound. Additional details are available on the fenoldopam mesylate profile page.
The generic ingredient in CORLOPAM is fenoldopam mesylate. There are five drug master file entries for this compound. Additional details are available on the fenoldopam mesylate profile page.
Summary for 019922
| Tradename: | CORLOPAM |
| Applicant: | Hospira |
| Ingredient: | fenoldopam mesylate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 019922
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 10MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Sep 23, 1997 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
